Literature DB >> 16338026

Influence of HIV co-infection on hepatitis C immunopathogenesis.

Margaret James Koziel1.   

Abstract

The role of CD4(+) or CD8(+) T cells in chronic hepatitis C virus (HCV) infection is unclear. People with chronic infection have weak responses against HCV in the blood, but HCV-specific responses are present within liver. The prevailing hypothesis of liver injury in HCV is that CD4(+) and CD8(+) T cell responses mediate HCV-related liver damage but are ineffectual at clearing the chronic infection. However, we recently reported that vigorous CD4(+) responses that produce interferon gamma (IFNgamma) early in infection are correlated with slower rates of disease progression, and compartmentalize to the liver. People with chronic HIV and HCV co-infection, particularly those with CD4(+) <200 cells/mm(3), have a higher rate of fibrosis development and severe liver disease. Co-infected people have variable degrees of immunosuppression that may provide insight into the relationship between cellular immune functions and the degree of liver damage as assessed by liver biopsy. People with co-infection may have quantitative or qualitative differences in the immune responses. We recently found a relationship between CD4(+) immune responses and liver histology. There are qualitative differences in the CD4(+) responses found in the liver in co-infected people compared to those with HCV alone, whereas no such differences are found when CD8(+) responses are measured. Neither CD4(+) nor CD8(+) responses correlate with the peripheral CD4 count.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16338026     DOI: 10.1016/j.jhep.2005.11.006

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  3 in total

1.  Prevalence and risk factors for patient-reported joint pain among patients with HIV/hepatitis C coinfection, hepatitis C monoinfection, and HIV monoinfection.

Authors:  Alexis Ogdie; Wyki Gina Pang; Kimberly A Forde; Bhangle D Samir; Lakeisha Mulugeta; Kyong-Mi Chang; David E Kaplan; Valerianna K Amorosa; Jay R Kostman; Rajender K Reddy; Ralph H Schumacher; Vincent Lo Re
Journal:  BMC Musculoskelet Disord       Date:  2015-04-19       Impact factor: 2.362

2.  Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients.

Authors:  Caterina Sagnelli; Caterina Uberti-Foppa; Hamid Hasson; Giulia Bellini; Carmine Minichini; Stefania Salpietro; Emanuela Messina; Diletta Barbanotti; Marco Merli; Francesca Punzo; Nicola Coppola; Adriano Lazzarin; Evangelista Sagnelli; Francesca Rossi
Journal:  PLoS One       Date:  2017-07-31       Impact factor: 3.240

Review 3.  Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact.

Authors:  Anna Linda Zignego; Carlo Giannini; Laura Gragnani; Alessia Piluso; Elisa Fognani
Journal:  J Transl Med       Date:  2012-08-03       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.